To view this email as a web page, click here.
 
FDA clears novel breast cancer drug
FDA approved alpelisib (Piqray) tablets, the first PI3K inhibitor to treat breast cancer, to be used in combination with fulvestrant (Faslodex).
Read more
 
Understanding the copay accumulator debate
From our sister brand, Managed Healthcare Executive: Bruce A. Feinberg, vice president and chief medical officer at Cardinal Health Specialty Solutions, helped attendees at the recent 2019 Asembia Specialty Pharmacy Summit understand the nuances of the ongoing copay accumulator debate.
Read more
 
Revolutionary smartphone device could offer migraine sufferers hope
FDA granted market authorization for a novel smartphone-controlled device to treat acute migraines. Find out why it is unique.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.